Blackmores Ltd (ASX: BKL) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Blackmores Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.43 billion
P/E Ratio 46.08
Dividend Yield 1.44%
Shares Outstanding 19.43 million
Earnings per share 1.576
Dividend per share 1.26
Year To Date Return -19.70%
Earnings Yield 2.17%
Franking 100%
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Blackmores Ltd (ASX: BKL)
Latest News

Matthew Booker, portfolio manager and co-founder of Spheria Asset Management
Ask a Fund Manager

These are the 2 best small cap ASX shares to buy right now: fund manager

Investors shouldn’t buy stories, they should buy fundamentals.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

Top brokers name 3 ASX shares to sell next week

Brokers aren't feeling overly positive on these shares...

Read more »

A man sitting at his dining table looks at his laptop and ponders whether the Lynas share price is a buy today
Consumer Staples & Discretionary Shares

Why is the Blackmores (ASX:BKL) share price sliding today?

Blackmores shares are starting Tuesday in negative territory.

Read more »

Business woman watching stocks and trends while thinking
Share Market News

5 things to watch on the ASX 200 on Tuesday

A good day is expected for the ASX 200 on Tuesday...

Read more »

Business executive aiming bow and arrow at target.
Consumer Staples & Discretionary Shares

Own Blackmores (ASX:BKL) shares? Here’s how the company is aiming for 1 billion consumers

The natural health products company has some ambitious growth plans.

Read more »

Close-up photo of a back jean pocket with Australian dollar bills in it and a hand reaching in to collect the notes
Dividend Investing

5 ASX shares trading ex-dividend next week

These shares will soon trade ex-dividend...

Read more »

Business man marking Sell on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to sell today

Here’s why brokers aren’t feeling positive about these ASX shares…

Read more »

a woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Broker Notes

Why this broker just downgraded Blackmores (ASX:BKL) shares to a sell rating

Blackmores has been hit with a sell rating today...

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
22 Mar 2022 $0.6300 100.00% Interim 12 Apr 2022
08 Sep 2021 $0.4200 100.00% Final 24 Sep 2021
22 Mar 2021 $0.2900 100.00% Interim 12 Apr 2021
27 Aug 2019 $0.7000 100.00% Final 12 Sep 2019
04 Mar 2019 $1.5000 100.00% Interim 20 Mar 2019
26 Sep 2018 $1.5500 100.00% Final 12 Oct 2018
07 Mar 2018 $1.5000 100.00% Interim 22 Mar 2018
11 Sep 2017 $1.4000 100.00% Final 26 Sep 2017
07 Mar 2017 $1.3000 100.00% Interim 22 Mar 2017
06 Sep 2016 $2.1000 100.00% Final 21 Sep 2016
09 Mar 2016 $2.0000 100.00% Interim 24 Mar 2016
04 Sep 2015 $1.3500 100.00% 22 Sep 2015
23 Mar 2015 $0.6800 100.00% 13 Apr 2015
10 Sep 2014 $0.8300 100.00% Final 03 Oct 2014
05 Mar 2014 $0.4400 100.00% Interim 02 Apr 2014
24 Sep 2013 $0.8300 100.00% Final 18 Oct 2013
07 Mar 2013 $0.4400 100.00% Interim 04 Apr 2013
25 Sep 2012 $0.8300 100.00% Final 16 Oct 2012
04 Mar 2010 $0.4200 100.00% Interim 25 Mar 2010
04 Sep 2009 $0.5700 100.00% Final 24 Sep 2009
27 Feb 2009 $0.3900 100.00% Interim 19 Mar 2009

BKL ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Blackmores Ltd

Blackmores Limited (BKL) is Australia’s leading natural health company, providing a range of vitamin, minerals, herbal and nutritional supplements to communities around the world. The company was founded by the vision and passion of Maurice Blackmore in 1931 and went on to publicly list on the ASX in 1985. 

Since then, Blackmores has made a series of acquisitions along its journey and has expanded into key Asian markets. In 2015, Blackmores shares treated investors to some particularly enormous gains, while it also became the first company listed on the ASX to hit $200 per share.

BKL Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
17 May 2022 $73.35 $0.68 0.94% 26,834 $73.25 $73.75 $72.17
16 May 2022 $72.67 $0.36 0.50% 59,377 $73.20 $74.24 $72.00
13 May 2022 $72.31 $1.63 2.31% 70,462 $71.55 $74.83 $71.08
12 May 2022 $70.68 $-1.11 -1.55% 49,937 $70.58 $71.55 $69.23
11 May 2022 $71.79 $0.71 1.00% 20,549 $71.80 $71.97 $70.16
10 May 2022 $71.08 $0.98 1.40% 42,283 $69.00 $71.34 $68.38
09 May 2022 $70.10 $-1.30 -1.82% 42,123 $70.80 $70.98 $69.35
06 May 2022 $71.40 $-1.11 -1.53% 24,818 $72.37 $72.69 $71.00
05 May 2022 $72.51 $0.61 0.85% 17,049 $72.50 $72.71 $71.57
04 May 2022 $71.90 $-0.54 -0.75% 9,341 $72.97 $72.97 $71.33
03 May 2022 $72.44 $0.81 1.13% 14,701 $71.12 $72.92 $71.12
02 May 2022 $71.63 $-0.72 -1.00% 14,157 $71.60 $71.74 $70.85
29 Apr 2022 $72.35 $1.68 2.38% 40,727 $70.51 $72.77 $70.50
28 Apr 2022 $70.67 $0.21 0.30% 20,328 $70.20 $71.53 $70.20
27 Apr 2022 $70.46 $0.06 0.09% 32,593 $70.20 $71.01 $69.70
26 Apr 2022 $70.40 $-1.41 -1.96% 25,021 $71.25 $71.65 $69.60
22 Apr 2022 $71.81 $-0.14 -0.19% 15,713 $71.75 $72.62 $71.31
21 Apr 2022 $71.95 $-1.02 -1.40% 19,288 $73.31 $73.92 $71.67
20 Apr 2022 $72.97 $1.66 2.33% 39,667 $71.40 $73.47 $71.40

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
02 Mar 2022 Sharon Warburton Buy 397 $29,755
On-market trade.
01 Mar 2022 David Ansell Buy 587 $43,280
On-market trade.
21 Dec 2021 Anne Templeman-Jones Buy 250 $22,145
On-market trade.
11 Nov 2021 Erica Mann Buy 500 $50,000
On-market trade.
10 Nov 2021 Erica Mann Buy 492 $49,987
On-market trade.
09 Nov 2021 Erica Mann Buy 496 $49,996
On-market trade.
05 Nov 2021 Sharon Warburton Buy 500 $49,785
On-market trade.
10 Jun 2021 Anne Templeman-Jones Buy 652 $44,922
On-market trade. Avg Price.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Stephen Patrick Roche Non-Executive Director Sep 2021
Mr Roche has ASX listed experience, as both a director and as a CEO. He has experience in strategy, business development and supply chains across the pharmacy, healthcare, retail and consumer markets. Stephen has over 20 years' experience in pharmacy, manufacturing operations and supply chains, developed in roles which include his eleven-year tenure as Managing Director and CEO of Australian Pharmaceutical Industries Limited (API). Stephen is currently Managing Director of Bridgestone Australia & New Zealand. Prior to his leadership of API, Stephen held senior executive roles at Mayne and Faulding extending across health and primary care services, distribution and business development. Stephen currently serves as a Non-Executive Director of Myer Family Investments Pty Ltd, Baby Bunting Limited and Adelaide Football Club. He was previously Vice Chairman of Bridgestone China & Asia Pacific, the founding Chairman of the Priceline Sisterhood Foundation and a Non-Executive Director of Epworth Healthcare and Gold Cross Products and Services.
Ms Anne Louise Templeman-Jones Non-Executive ChairmanNon-Executive Director Oct 2020
Ms Templeman-Jones brings a wealth of corporate experience and is currently serving as a Non-Executive Director of Commonwealth Bank of Australia, GUD Holdings Limited and Worley Limited. During her 30 year executive career, Anne has held a number of leadership positions in corporate and private banking with domestic and offshore banks including Westpac Banking Corporation, Australia and New Zealand Banking Group Ltd, and Bank of Singapore. Anne is the former Chairperson of Commonwealth Bank's financial advice companies and has served on the boards of The Citadel Group Ltd, Cuscal Ltd, HT&E Limited, Pioneer Credit Ltd, Notre Dame University, TAL Superannuation Fund, and HBF Limited (private and general insurance companies). Anne has experience in strategy, financial and nonfinancial risk, and corporate governance. Anne is also a Director of the Cyber Security Research Centre Ltd. She is also member of Risk & Technology Committee.
Ms Sharon Lee Warburton Non-Executive Director Apr 2021
Sharon has board and executive experience in corporate strategy, business operations, finance, accounting and risk management, along with expertise in governance and remuneration. She is currently a Non-Executive Director and Chair of the Audit and Risk Committee of Wesfarmers Limited, as well as being a Non-Executive Director of Gold Road Resources Limited and Worley Limited. Sharon has also been a part time member of the Takeovers Panel since 2015, and is an Adjunct Professor in Leadership and Strategy at Curtin University's Faculty of Business and Law. She is also member of Risk & Technology Committee.

Mr David Ansell Non-Executive Director Oct 2013
Mr Ansell has a career in consumer-facing organisations in Australia, Asia and the United States. David played a pivotal role in the start-up years of Foxtel, was CEO of advertising agency Saatchi & Saatchi, Managing Director of Mars Incorporated in Australia, and President of a global Mars unit based in the United States. David has a operating and supply chain skill set and understanding of brand and customer strategy. David recently stepped down as Managing Director of Jacobs Douwe Egberts Peets, after six years running Australia and New Zealand's largest pure play coffee Company. Since then, he has led the acquisition of the Campos Coffee Company, which he now Chairs as an Independent Director. David is a former Director of the peak body of cycling in this country, Cycling Australia, where he served for five years until early 2020. He is also member of Risk & Technology Committee.
Ms Wendy Margaret Stops Non-Executive Director Apr 2021
Ms Stops is Chair of the Risk & Technology Committee. She brings global information technology, operational and risk management experience with leadership roles in Asia Pacific and operational and risk management globally. Wendy is currently a Non-Executive Director with the Coles Group and Fitted for Work, a Council Member of the University of Melbourne, Chair of the Industry Advisory Board for the Melbourne Business School's Centre for Business Analytics, a member of the Digital Experts Advisory Panel for the Department of Prime Minister and Cabinet's Digital Taskforce and a member of the AICD's Governance of Technology & Innovation Panel. She was previously a Non-Executive Director of the Commonwealth Bank of Australia (2015-2020) and Altium Ltd (2018-2019).
Mr Alastair Symington Managing DirectorChief Executive Officer Sep 2019
Mr Symington brings global FMCG experience with leadership roles in health and beauty categories across multiple geographies. Prior to joining Blackmores Alastair was the Senior Vice President of APAC, Latin America and the Middle East for Coty based in Dubai. He has experience in commercial operations across multiple geographies during his time at P&G and Coty having held roles in Market Strategy and Planning across APAC (P&G) based in Singapore, Managing Director China Wella (P&G), based in Shanghai, Head of Emerging Markets Wella) P&G, based in Geneva, and SVP Consumer Beauty, Coty based in Dubai. Alastair started his career in Australia and has a deep understanding of consumer retail and brand marketing in the local market having held roles at both at Nestle and Gillette.
Ms Erica Mann Non-Executive Director Sep 2021
Ms Mann has experience and understanding of complementary medicines and naturopathic principles. She has experience in over-the-counter health care products. She has worked in leadership roles in organisations at the head of health technology developments. Erica's most recent executive role was President & Head of Bayer's Global Consumer Health Division, where she directed every aspect of consumer self-care companies globally. Erica also served as Chair of the World Self-Medication Industry, a body that sets standards and guidelines for the design and labelling of non-prescription medicines and dietary supplements. Erica currently serves as a Non-Executive Director of Kellogg Company (NYSE: K), Perrigo Company PLC (NYSE: PRGO) and Supervisory Board Member at Koninklijke DSM N.V (AMS: DSM). She previously held executive positions on the boards of South African Pharmaceutical Manufacturers' Association, Medicines Australia and the International Association of Infant Food Manufacturers.
Mr William (Bill) Michael Hundy Company Secretary Apr 2022
Gunther Burghardt Chief Financial Officer
Cecile Cooper Chief Governance Officer
Joanne Smith Chief Marketing and Innovation Officer
Jeremy Cowan Chief Operations Officer
Jane Franks Chief People Officer
William (Bill) Michael Hundy Company Secretary
Adjunct Professor Lesley Braun Director Blackmores Institute
Kitty Liu Managing Director China
Dean Garvey Managing Director International

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 3,611,759 18.65%
JP Morgan Nominees Australia Limited 2,986,113 15.42%
Mr M C Blackmore 2,197,467 11.35%
Citicorp Nominees Pty Limited 978,970 5.06%
National Nominees Limited 725,702 3.75%
Blackmore Foundation Pty Limited 696,535 3.60%
BNP Paribas Nominees Pty Ltd (DRP) 238,119 1.23%
BNP Paribas Nominees Pty Ltd (Agency Lending A/C) 225,981 1.17%
Mrs E M Whellan 150,347 0.78%
Mrs P G Wright 122,265 0.63%
Rathvale Pty Limited 113,088 0.58%
Marcus Blackmore Holdings P/L (Blackmores S/F A/C) 99,589 0.51%
Mr R Shepherd 88,179 0.46%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd DRP 56,219 0.29%
Netwealth Investments Limited (Wrap Services A/C) 41,974 0.22%
BNP Paribas Nominees Pty Ltd Six Sis Ltd <Drp A/C> 41,422 0.21%
Citicorp Nominees Pty Limited (Colonial First State Inv A/C) 40,071 0.21%
Powerwrap Limited (Scheme IML Trades A/C) 38,325 0.20%
Mr John Taylor 35,465 0.18%
Ms Margaret Dittman 32,191 0.17%